JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Investor Presentation
JBCHEPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Torrent Pharmaceuticals is acquiring a 46.39% stake in JB Pharma for about ₹11,917 crore at ₹1,600 per share, which will trigger a mandatory open offer for an additional 26% stake at ₹1,639.18 per share. Following the acquisition, Torrent will merge into JB Pharma with Torrent as the surviving listed entity, giving JB Pharma shareholders 51 Torrent shares for every 100 JB Pharma shares held. The combined company will become the 5th largest pharma firm in India by sales and 4th by prescriptions, with combined revenue exceeding ₹15,000 crore and EBITDA of ₹4,800+ crore. The deal is expected to take 15-18 months to complete, pending approvals from CCI, SEBI, stock exchanges, shareholders, and NCLT.
This is a major exit event for JB Pharma shareholders — existing investors get a cash exit option at a premium via the open offer while also becoming shareholders in a much larger combined pharma company. JB Pharma will cease to exist as a standalone listed stock, so investors will eventually hold Torrent Pharma shares instead.